(Total Views: 84)
Posted On: 12/03/2024 8:19:48 AM
Post# of 25471
$AIMD MOU Highlights
1. ???? Ainos and Taiwan Tanabe Seiyaku have signed an MOU to advance the manufacturing and Taiwan market promotion of VELDONA®️ for Sjögren’s syndrome. This international cooperation addresses the unmet need for effective treatments and leverages clinical benefits from prior Phase 3 studies. Taiwan Tanabe Seiyaku, a subsidiary of Mitsubishi Tanabe Pharma in Japan, excels in Taiwan and neighboring markets with specialty therapeutics for autoimmune diseases, diabetes, and other major health conditions. #PharmaPartnerships #DrugOutlicensing #PharmaDeals #SjogrensSyndrome #AutoimmuneDisease #OrphanDrug #RareDisease #ClinicalTrial #AinosInc #AIMD $AIMD #MitsubishiTanabePharma
1. ???? Ainos and Taiwan Tanabe Seiyaku have signed an MOU to advance the manufacturing and Taiwan market promotion of VELDONA®️ for Sjögren’s syndrome. This international cooperation addresses the unmet need for effective treatments and leverages clinical benefits from prior Phase 3 studies. Taiwan Tanabe Seiyaku, a subsidiary of Mitsubishi Tanabe Pharma in Japan, excels in Taiwan and neighboring markets with specialty therapeutics for autoimmune diseases, diabetes, and other major health conditions. #PharmaPartnerships #DrugOutlicensing #PharmaDeals #SjogrensSyndrome #AutoimmuneDisease #OrphanDrug #RareDisease #ClinicalTrial #AinosInc #AIMD $AIMD #MitsubishiTanabePharma
(0)
(0)
